Clinical symptoms of skin, nails, and joints manifest independently in patients with concomitant psoriasis and psoriatic arthritis

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Wittkowski, Knut M ^a   Leonardi, Craig ^b   Gottlieb, Alice ^c   Menter, Alan ^d   Krueger, Gerald G ^e   Tebbey, Paul W ^f   Belasco, Jennifer ^a   Soltani Arabshahi, Razieh ^e   Gray, John ^a   Horn, Liz ^f   Krueger, James G ^a   The International Psoriasis Council, ^f  

^a ROCKEFELLER UNIVERSITY   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TUFTS UNIVERSITY   (United States)

^d BAYLOR UNIVERSITY   (United States)

^e UNIVERSITY OF UTAH   (United States)

^f International Psoriasis Council   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTHROPATHY; ARTICLE; BUTTOCK; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DISEASE SEVERITY; EXTENDED 10 AREA LINEAR PSORIASIS AREA AND SEVERITY INDEX; FACE DISORDER; FEMALE; FOOT DISEASE; HAND DISEASE; HUMAN; LATTICE PHYSICIAN GLOBAL ASSESSMENT; MAJOR CLINICAL STUDY; MALE; NAIL ASSESSMENT AND JOINT ASSESSMENT; NAIL DISEASE; PSORIASIS; PSORIASIS VULGARIS; PSORIASIS WEIGHTED EXTENT AND SEVERITY INDEX; PSORIATIC ARTHRITIS; PSORIATIC ARTHRITIS ASSESSMENT; PSORIATIC ARTHRITIS SCREENING AND EVALUATION QUESTIONNAIRE; QUESTIONNAIRE; SCALP; SKIN MANIFESTATION; SYMPTOM; THORAX DISEASE; UNITED STATES; ADOLESCENT; DISEASE COURSE; JOINT; MIDDLE AGED; NAIL; PHASE 2 CLINICAL TRIAL (TOPIC); SKIN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, PSORIATIC; CLINICAL TRIALS, PHASE II AS TOPIC; DISEASE PROGRESSION; FEMALE; HUMANS; JOINTS; MALE; MIDDLE AGED; NAILS; SKIN; YOUNG ADULT;

EID: 79957853898     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020279     Document Type: Article

References (33)

1. Nestle FO, Kaplan DH, Barker J, (2009) Psoriasis. N Engl J Med 361: 496-509.
2. Gladman DD, Antoni C, Mease P, Clegg DO, Nash P, (2005) Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 64 (Suppl 2): ii 14-17.
3. Langley RG, Krueger GG, Griffiths CE, (2005) Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 64 (Suppl 2): ii 18-23.
4. McGonagle D, Benjamin M, Tan AL, (2009) The pathogenesis of psoriatic arthritis and associated nail disease: not autoimmune after all? Curr Opin Rheumatol 21: 340-347.
5. Gladman DD, (2009) Psoriatic arthritis. Dermatol Ther 22: 40-55.
6. Ritchlin C, (2007) Psoriatic disease-from skin to bone. Nat Clin Pract Rheumatol 3: 698-706.
7. Makredes M, Robinson D Jr, Bala M, Kimball AB, (2009) The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis. J Am Acad Dermatol 61: 405-410.
8. McGonagle D, Tan AL, Benjamin M, (2009) The nail as a musculoskeletal appendage-implications for an improved understanding of the link between psoriasis and arthritis. Dermatology 218: 97-102.
9. Cohen MR, Reda DJ, Clegg DO, (1999) Baseline relationships between psoriasis and psoriatic arthritis: analysis of 221 patients with active psoriatic arthritis. Department of Veterans Affairs Cooperative Study Group on Seronegative Spondyloarthropathies. J Rheumatol 26: 1752-1756.
10. Duffin KC, Chandran V, Gladman DD, Krueger GG, Elder JT, et al. (2008) Genetics of psoriasis and psoriatic arthritis: update and future direction. J Rheumatol 35: 1449-1453.
11. Castelino M, Barton A, (2010) Genetic susceptibility factors for psoriatic arthritis. Curr Opin Rheumatol 22: 152-156.
12. Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon R, et al. (2007) A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 80: 273-290.
13. Liu Y, Helms C, Liao W, Zaba LC, Duan S, et al. (2008) A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet 4: e1000041.
14. Rahman P, Sun S, Peddle L, Snelgrove T, Melay W, et al. (2006) Association between the interleukin-1 family gene cluster and psoriatic arthritis. Arthritis Rheum 54: 2321-2325.
15. Strange A, Capon F, Spencer CC, Knight J, Weale ME, et al. (2010) A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nature genetics 42: 985-990.
16. Nograles KE, Brasington RD, Bowcock AM, (2009) New insights into the pathogenesis and genetics of psoriatic arthritis. Nat Clin Pract Rheumatol 5: 83-91.
17. Goldstein I, Simon AJ, Ben Horin S, Matzri S, Koltakov A, et al. (2008) Synovial VLA-1+ T cells display an oligoclonal and partly distinct repertoire in rheumatoid and psoriatic arthritis. Clin Immunol 128: 75-84.
18. Ritchlin C, (2006) Newer therapeutic approaches: spondyloarthritis and uveitis. Rheum Dis Clin North Am 32: 75-90.
19. Feldman SR, Krueger GG, (2005) Psoriasis assessment tools in clinical trials. Ann Rheum Dis 64: ii65-68.
20. Dominguez PL, Husni ME, Holt EW, Tyler S, Qureshi AA, (2009) Validity, reliability, and sensitivity-to-change properties of the psoriatic arthritis screening and evaluation questionnaire. Arch Dermatol Res 301: 573-579.
21. Langley RG, Ellis CN, (2004) Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment. J Am Acad Dermatol 51: 563-569.
22. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, et al. (2009) Research electronic data capture (REDCap) -A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42: 377-381.
23. Morales JF, Song T, Auerbach AD, Wittkowski KM, (2008) Phenotyping genetic diseases using an extension of μ-scores for multivariate data. Stat Appl Genet Mol Biol 7: 19.
24. Spearman C, (1904) The proof and measurement of association between two things. Am J Psychol 15: 72-101.
25. Jones SM, Armas JB, Cohen MG, Lovell CR, Evison G, et al. (1994) Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol 33: 834-839.
26. Jones SM, McHugh NJ, (1998) The temporal relationship between joints, skin and nail disease in psoriatic arthritis: a prospective study of two years. Arthritis Rheum 41: S334.
27. Elkayam O, Ophir J, Yaron M, Caspi D, (2000) Psoriatic arthritis: interrelationships between skin and joint manifestations related to onset, course and distribution. Clin Rheumatol 19: 301-305.
28. Gottlieb AB, Mease PJ, Jackson JM, Eisen D, Xia HA, et al. (2006) Clinical characteristics of psoriatic arthritis and psoriasis in dermatologists' offices. J Dermatolog Treat 17: 279-287.
29. Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel SE, et al. (2009) Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum 61: 233-239.
30. Tan AL, Grainger AJ, Tanner SF, Emery P, McGonagle D, (2006) A high-resolution magnetic resonance imaging study of distal interphalangeal joint arthropathy in psoriatic arthritis and osteoarthritis: are they the same? Arthritis Rheum 54: 1328-1333.
31. Tan AL, Benjamin M, Toumi H, Grainger AJ, Tanner SF, et al. (2007) The relationship between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic arthritis-a high-resolution MRI and histological study. Rheumatology (Oxford) 46: 253-256.
32. Wittkowski KM, Haider A, Sehayek E, Suarez-Farinas M, Pellegrino M, et al. (2006) Bioinformatics tools enabling u-statistics for microarrays. Conf Proc IEEE Eng Med Biol Soc 1: 3464-3469.
33. Ramagopalan SV, McMahon R, Dyment DA, Sadovnick AD, Ebers GC, et al. (2009) An extension to a statistical approach for family based association studies provides insights into genetic risk factors for multiple sclerosis in the HLA-DRB1 gene. BMC Med Genet 10: 10.